In order to investigate the effects of zinc on the p53 signaling pathway, MCF-7 breast cancer cells were treated with 5 μM TPEN, an intracellular membrane-permeable zinc chelator (structure shown in Fig. 1A). Here, TP53 is linked to breast carcinoma.